TDOC Teladoc Health Inc.

Teladoc Health Announces Availability of Best Doctors Oncology Insight in Canada

Teladoc Health Announces Availability of Best Doctors Oncology Insight in Canada

Now available to Sun Life Financial clients, Oncology Insight provides patients facing cancer access to the world’s leading oncologists, backed by recommended treatment options from IBM Watson for Oncology

TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- , the global leader in virtual care, announced today the availability of the Best Doctors Oncology Insight service in Canada. Oncology Insight enables individuals with a cancer diagnosis to receive an in-depth medical review from a world-renowned expert oncologist who has access to the cognitive computing capabilities of IBM Watson for Oncology. Oncology Insight is now available to Sun Life Assurance Company of Canada’s group benefits members who have Best Doctors Expert Medical Services through their Extended Health Care (EHC) plan.

“Providing our members with access to the finest medical expertise is a critical component to care," said JM Lavoie, assistant vice president, Product Development, Group Benefits, Sun Life Financial Canada. “Best Doctors Oncology Insight helps our members ensure their treatment options have been carefully reviewed and they’re receiving the best care for their diagnosis.”

According to the Canadian Cancer Society, about one in two Canadians will develop cancer in their lifetimes. With Oncology Insight, members facing cancer diagnoses can request a medical opinion by an expert oncologist who reviews medical records, retests pathology results, and reviews the latest clinical research using IBM Watson for Oncology. IBM Watson for Oncology is an AI decision support tool that complements the work of oncologists, supporting them in clinical decision-making by evaluating the patient’s clinical data, including dozens of clinical attributes relevant to the individual’s unique diagnosis. After thorough case review, the Best Doctors expert oncologist validates the diagnosis and provides the patient with evidence-based, personalized treatment recommendations.

“With Oncology Insight, experts can use augmented intelligence from IBM Watson for Oncology to create personalized treatment recommendations, empowering patients and physicians with actionable data that can help them make more informed decisions,” said Dr. Lewis Levy, chief medical officer, Teladoc Health. "With the peer-reviewed literature and evidence-based references that Watson presents, oncologists can quickly access and review treatment options that they may not have otherwise considered. We’re proud to work with Sun Life Financial to help their members diagnosed with cancer.”

For more information about Best Doctors Oncology Insight, visit .

About Teladoc Health

A mission-driven organization, Teladoc Health, Inc. is successfully transforming how people access and experience healthcare, with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical services, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery. For more information, please visit  or follow  on Twitter.

Media Contacts:

Justin Joseph

Director of Public Relations

Teladoc Health

617-359-5522



 

EN
11/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 5...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10th, 2026, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at .  About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care pr...

 PRESS RELEASE

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31, 2025 (“Full Year 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 (“Fourth Quarter 2024”) and full year ended December 31, 2024 (“Full Year 2024”). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat...

 PRESS RELEASE

Teladoc Health Appoints Michael Smith, Experienced Insurance and Finan...

Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements ...

 PRESS RELEASE

Teladoc Health to Announce Fourth Quarter 2025 Financial Results

Teladoc Health to Announce Fourth Quarter 2025 Financial Results NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch